BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1166 related articles for article (PubMed ID: 28148226)

  • 21. The distinct category of healthcare associated bloodstream infections.
    Lenz R; Leal JR; Church DL; Gregson DB; Ross T; Laupland KB
    BMC Infect Dis; 2012 Apr; 12():85. PubMed ID: 22487002
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The epidemiology of bloodstream infection contributing to mortality: the difference between community-acquired, healthcare-associated, and hospital-acquired infections.
    Mun SJ; Kim SH; Kim HT; Moon C; Wi YM
    BMC Infect Dis; 2022 Apr; 22(1):336. PubMed ID: 35382769
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Etiologies of community-onset urinary tract infections requiring hospitalization and antimicrobial susceptibilities of causative microorganisms.
    Chiu CC; Lin TC; Wu RX; Yang YS; Hsiao PJ; Lee Y; Lin JC; Chang FY
    J Microbiol Immunol Infect; 2017 Dec; 50(6):879-885. PubMed ID: 28087318
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Emergence of community-associated methicillin-resistant Staphylococcus aureus strains as a cause of healthcare-associated bloodstream infections in Korea.
    Park SH; Park C; Yoo JH; Choi SM; Choi JH; Shin HH; Lee DG; Lee S; Kim J; Choi SE; Kwon YM; Shin WS
    Infect Control Hosp Epidemiol; 2009 Feb; 30(2):146-55. PubMed ID: 19128184
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A comparative study of antimicrobial resistance rates and phylogenetic groups of community-acquired versus hospital-acquired invasive Escherichia coli.
    Ferjani S; Saidani M; Amine FS; Boutiba Ben Boubaker I
    Med Mal Infect; 2015 Apr; 45(4):133-8. PubMed ID: 25725924
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Trends in paediatric bloodstream infections at a South African referral hospital.
    Dramowski A; Cotton MF; Rabie H; Whitelaw A
    BMC Pediatr; 2015 Apr; 15():33. PubMed ID: 25884449
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk factors and mortality of healthcare-associated and community-acquired Staphylococcus aureus bacteraemia.
    Bassetti M; Trecarichi EM; Mesini A; Spanu T; Giacobbe DR; Rossi M; Shenone E; Pascale GD; Molinari MP; Cauda R; Viscoli C; Tumbarello M
    Clin Microbiol Infect; 2012 Sep; 18(9):862-9. PubMed ID: 21999245
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative antimicrobial susceptibility of aerobic and facultative bacteria from community-acquired bacteremia to ertapenem in Taiwan.
    Lee SC; Huang SS; Lee CW; Fung CP; Lee N; Shieh WB; Siu LK
    BMC Infect Dis; 2007 Jul; 7():79. PubMed ID: 17640342
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Staphylococcus aureus bacteremia in an Indian tertiary care hospital: observational study on clinical epidemiology, resistance characteristics, and carriage of the Panton-Valentine leukocidin gene.
    Eshwara VK; Munim F; Tellapragada C; Kamath A; Varma M; Lewis LE; Mukhopadhyay C
    Int J Infect Dis; 2013 Nov; 17(11):e1051-5. PubMed ID: 23891294
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Does HIV status affect the aetiology, bacterial resistance patterns and recommended empiric antibiotic treatment in adult patients with bloodstream infection in Cambodia?
    Phe T; Vlieghe E; Reid T; Harries AD; Lim K; Thai S; De Smet B; Veng C; Kham C; Ieng S; van Griensven J; Jacobs J
    Trop Med Int Health; 2013 Apr; 18(4):485-94. PubMed ID: 23294446
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Resistance profiles and risk factors of resistant microorganisms in bacteraemia of abdominal origin.
    Martín Jaramago J; Armero Ibáñez R; Camarena Miñana JJ; Morales Suárez-Varela M
    Rev Esp Anestesiol Reanim; 2017 Nov; 64(9):490-498. PubMed ID: 28434558
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antimicrobial resistance trends in bloodstream infections at a large teaching hospital in China: a 20-year surveillance study (1998-2017).
    Tian L; Zhang Z; Sun Z
    Antimicrob Resist Infect Control; 2019; 8():86. PubMed ID: 31161033
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical implications of antimicrobial resistance for therapy.
    Macgowan AP;
    J Antimicrob Chemother; 2008 Nov; 62 Suppl 2():ii105-14. PubMed ID: 18819975
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Staphylococcus aureus bloodstream infections: risk factors, outcomes, and the influence of methicillin resistance in Calgary, Canada, 2000-2006.
    Laupland KB; Ross T; Gregson DB
    J Infect Dis; 2008 Aug; 198(3):336-43. PubMed ID: 18522502
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Microbiology of Bloodstream Infection: 20-Year Trends from the SENTRY Antimicrobial Surveillance Program.
    Diekema DJ; Hsueh PR; Mendes RE; Pfaller MA; Rolston KV; Sader HS; Jones RN
    Antimicrob Agents Chemother; 2019 Jul; 63(7):. PubMed ID: 31010862
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Healthcare-associated, community-acquired and hospital-acquired bacteraemic urinary tract infections in hospitalized patients: a prospective multicentre cohort study in the era of antimicrobial resistance.
    Horcajada JP; Shaw E; Padilla B; Pintado V; Calbo E; Benito N; Gamallo R; Gozalo M; Rodríguez-Baño J; ; ;
    Clin Microbiol Infect; 2013 Oct; 19(10):962-8. PubMed ID: 23279375
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antibiotic Guidelines for Critically Ill Patients in Nigeria.
    Oladele RO; Ettu AO; Medugu N; Habib A; Egbagbe E; Osinaike T; Makanjuola OB; Ogunbosi B; Irowa OO; Ejembi J; Uwaezuoke NS; Adeleke G; Mutiu B; Ogunsola F; Rotimi V
    West Afr J Med; 2023 Sep; 40(9):962-972. PubMed ID: 37768104
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nosocomial bloodstream infections caused by Escherichia coli and Klebsiella pneumoniae resistant to third-generation cephalosporins, Finland, 1999-2013: Trends, patient characteristics and mortality.
    Martelius T; Jalava J; Kärki T; Möttönen T; Ollgren J; Lyytikäinen O;
    Infect Dis (Lond); 2016; 48(3):229-34. PubMed ID: 26577519
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Cohort Study of Risk Factors That Influence Empirical Treatment of Patients with Acute Pyelonephritis.
    Bosch-Nicolau P; Falcó V; Viñado B; Andreu A; Len O; Almirante B; Pigrau C
    Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28971876
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Descriptive epidemiology of Escherichia coli bacteraemia in England, April 2012 to March 2014.
    Bou-Antoun S; Davies J; Guy R; Johnson AP; Sheridan EA; Hope RJ
    Euro Surveill; 2016 Sep; 21(35):. PubMed ID: 27608263
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 59.